Advertisement

Medical and Behavioral Health Information Gathering by Value-Based Integrated Case Managers

  • Roger G. Kathol
  • Rachel L. Andrew
  • Michelle Squire
  • Peter J. Dehnel
Chapter

Chapter Objectives

  • To put into context the role of cross-disciplinary health condition information gathering for use in value-based integrated case management.

  • To illustrate assessment content needed for assistance to comorbid individuals with common behavioral health conditions.

  • To illustrate assessments content needed for assistance to comorbid individuals with common chronic general medical disorders.

  • To discuss utilization of gathered information in the development of clinical goals and actions.

Keywords

Cross-disciplinary VB-ICM assessments Core disease information retrieval 

References

  1. 1.
    National Institute on Alcohol Abuse and Alcoholism. Alcohol use disorder. National Institutes of Health; 2017.Google Scholar
  2. 2.
    Wachkermah R, Minnick M, Clapp P. Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment. Subst Abuse Rehabil. 2014;5:1–12.Google Scholar
  3. 3.
    Kane RL, Wall M, Potthoff S, Stromberg K, Dai Y, Meyer ZJ. The effect of alcoholism treatment on medical care use. Med Care. 2004;42(4):395–402.CrossRefPubMedGoogle Scholar
  4. 4.
    Parthasarathy S, Mertens J, Moore C, Weisner C. Utilization and cost impact of integrating substance abuse treatment and primary care. Med Care. 2003;41(3):357–67.PubMedGoogle Scholar
  5. 5.
    Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Batelaan NM, Spijker J, de Graaf R, Cuijpers P. Mixed anxiety depression should not be included in DSM-5. J Nerv Ment Dis. 2012;200(6):495–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Katon W, Russo J, Sherbourne C, Stein MB, Craske M, Fan MY, et al. Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychol Med. 2006;36(3):353–63.CrossRefPubMedGoogle Scholar
  8. 8.
    Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Marques L, Robinaugh DJ, LeBlanc NJ, Hinton D. Cross-cultural variations in the prevalence and presentation of anxiety disorders. Expert Rev Neurother. 2011;11(2):313–22.CrossRefPubMedGoogle Scholar
  10. 10.
    Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30(3):208–25.CrossRefPubMedGoogle Scholar
  11. 11.
    Roy-Byrne P, Stein MB, Russo J, Craske M, Katon W, Sullivan G, et al. Medical illness and response to treatment in primary care panic disorder. Gen Hosp Psychiatry. 2005;27(4):237–43.CrossRefPubMedGoogle Scholar
  12. 12.
    Sherbourne CD, Jackson CA, Meredith LS, Camp P, Wells KB. Prevalence of comorbid anxiety disorders in primary care outpatients. Arch Fam Med. 1996;5(1):27–34. discussion 5CrossRefPubMedGoogle Scholar
  13. 13.
    Salvador-Carulla L, Segui J, Fernandez-Cano P, Canet J. Costs and offset effect in panic disorders. Br J Psychiatry Suppl. 1995;27:23–8.CrossRefGoogle Scholar
  14. 14.
    Daley D, Van Der Oord S, Ferrin M, Cortese S, Danckaerts M, Doepfner M, et al. Practitioner review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder. J Child Psychol Psychiatry. 2017.  https://doi.org/10.1111/jcpp.12825.
  15. 15.
    Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135–44.CrossRefPubMedGoogle Scholar
  16. 16.
    Lowe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42(12):1194–201.CrossRefPubMedGoogle Scholar
  17. 17.
    Von Korff M, Goldberg D. Improving outcomes in depression. BMJ. 2001;323(7319):948–9.CrossRefGoogle Scholar
  18. 18.
    Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25(4):246–52.CrossRefPubMedGoogle Scholar
  19. 19.
    Egede LE. Disease-focused or integrated treatment: diabetes and depression. Med Clin North Am. 2006;90(4):627–46.CrossRefPubMedGoogle Scholar
  20. 20.
    Katon W, Unutzer J, Fan MY, Williams JW Jr, Schoenbaum M, Lin EH, et al. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care. 2006;29(2):265–70.CrossRefPubMedGoogle Scholar
  21. 21.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition: DSM 5. Washington, DC: American Psychiatric Press; 2013.CrossRefGoogle Scholar
  22. 22.
    Mai F. Somatization disorder: a practical review. Can J Psychiatr. 2004;49(10):652–62.CrossRefGoogle Scholar
  23. 23.
    Frostholm L, Petrie KJ, Ornbol E, Fink P. Are illness perceptions related to future healthcare expenditure in patients with somatoform disorders? Psychol Med. 2014;44(13):2903–11.CrossRefPubMedGoogle Scholar
  24. 24.
    Andersen NL, Eplov LF, Andersen JT, Hjorthoj CR, Birket-Smith M. Health care use by patients with somatoform disorders: a register-based follow-up study. Psychosomatics. 2013;54(2):132–41.CrossRefPubMedGoogle Scholar
  25. 25.
    Rask MT, Rosendal M, Fenger-Gron M, Bro F, Ornbol E, Fink P. Sick leave and work disability in primary care patients with recent-onset multiple medically unexplained symptoms and persistent somatoform disorders: a 10-year follow-up of the FIP study. Gen Hosp Psychiatry. 2015;37(1):53–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Rosendal M, Olde Hartman TC, Aamland A, van der Horst H, Lucassen P, Budtz-Lilly A, et al. “Medically unexplained” symptoms and symptom disorders in primary care: prognosis-based recognition and classification. BMC Fam Pract. 2017;18(1):18.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Yates GP, Feldman MD. Factitious disorder: a systematic review of 455 cases in the professional literature. Gen Hosp Psychiatry. 2016;41:20–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Kathol RG. Reassurance therapy: what to say to symptomatic patients with benign or non-existent medical disease. Int J Psychiatry Med. 1997;27(2):173–80.CrossRefPubMedGoogle Scholar
  29. 29.
    Schroder A, Rehfeld E, Ornbol E, Sharpe M, Licht RW, Fink P. Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br J Psychiatry. 2012;200(6):499–507.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Roger G. Kathol
    • 1
  • Rachel L. Andrew
    • 2
  • Michelle Squire
    • 3
  • Peter J. Dehnel
    • 4
  1. 1.Cartesian Solutions, Inc.™ and University of MinnesotaBurnsvilleUSA
  2. 2.Premera Blue Cross Mountlake TerraceUSA
  3. 3.ManahawkinUSA
  4. 4.Twin Cities Medical SocietyEdinaUSA

Personalised recommendations